Universal Ibogaine (TSXV:IBO) Current Accrued Expense : C$0.35 Mil (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Current Accrued Expense?

Universal Ibogaine's Current Accrued Expense for the quarter that ended in Jan. 2024 was C$0.35 Mil.

Universal Ibogaine's quarterly Current Accrued Expense increased from Jul. 2023 (C$0.32 Mil) to Oct. 2023 (C$0.41 Mil) but then declined from Oct. 2023 (C$0.41 Mil) to Jan. 2024 (C$0.35 Mil).

Universal Ibogaine's annual Current Accrued Expense increased from Mar. 2021 (C$0.07 Mil) to Jul. 2022 (C$0.28 Mil) and increased from Jul. 2022 (C$0.28 Mil) to Jul. 2023 (C$0.32 Mil).

Universal Ibogaine Current Accrued Expense Historical Data

The historical data trend for Universal Ibogaine's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Current Accrued Expense Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Current Accrued Expense

Get a 7-Day Free Trial

0.02

0.07

0.28

0.32

Universal Ibogaine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Current Accrued Expense	Get a 7-Day Free Trial															0.24	0.33	0.32	0.41	0.35

Universal Ibogaine Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Universal Ibogaine Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines